Further investigations are warranted to determine whether the gene therapy by targeting the FA/BRCA pathway combined with chemotherapy can used as an effective novel therapeutic regimen for patients with lung cancer, particular those with tumor relapse or progression after chemotherapy. Here, FANCA is linked to neoplasm.